TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive “A significant reduction in the NCI IRP AIDS program may be in order, and released funds should … increase the pool available to extramural research.” July 21, 1995
TCL Archive Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price October 14, 2011